Q4 2016 13F Holders as of 31 Dec 2016
-
Type / Class
-
Equity / Class A Stock
-
Shares outstanding
-
115,244,363
-
Total 13F shares
-
66,416,082
-
Share change
-
+1,333,314
-
Total reported value
-
$1,647,898,444
-
Put/Call ratio
-
14%
-
Price per share
-
$24.81
-
Number of holders
-
204
-
Value change
-
+$49,757,687
-
Number of buys
-
112
-
Number of sells
-
102
Institutional Holders of GLOBUS MEDICAL INC - Class A Stock (GMED) as of Q4 2016
As of 31 Dec 2016,
GLOBUS MEDICAL INC - Class A Stock (GMED) was held by
204 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
66,416,082 shares.
The largest 10 holders included
WELLINGTON MANAGEMENT GROUP LLP, VANGUARD GROUP INC, BlackRock Fund Advisors, JANUS CAPITAL MANAGEMENT LLC, Bank of New York Mellon Corp, ABERDEEN ASSET MANAGEMENT PLC/UK, STATE STREET CORP, Van Berkom & Associates Inc., BlackRock Institutional Trust Company, N.A., and OAK RIDGE INVESTMENTS LLC.
This page lists
204
institutional shareholders reporting positions in this security
for the Q4 2016 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.